IL-17A in COVID-19 Cases: a meta-analysis
Introduction: Numerous reviews, commentaries and opinion pieces have suggested targeting IL-17A as part of managing Coronavirus disease 2019 (COVID-19), the notorious pandemic caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). IL-17A is a proinflammatory cytokine attributed...
Saved in:
| Main Authors: | Sukayna Fadlallah, Marcel S Sham Eddin, Elias A Rahal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2021-11-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/15285 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of IL-6 and IL-17 in SARS CoV-2 Patients with Secondary Bacterial Pneumonia
by: May Raheem Ali, et al.
Published: (2023-02-01) -
The novel zoonotic COVID-19 pandemic: An expected global health concern
by: Carlo Contini, et al.
Published: (2020-03-01) -
Comparison οf Immune Responses Through Multiparametric T-Cell Cytokine Expression Profile Between Children with Convalescent COVID-19 or Multisystem Inflammatory Syndrome
by: Filippos Filippatos, et al.
Published: (2024-10-01) -
Evaluating the efficacy of different doses of tocilizumab in treating critically ill COVID–19 patients: a single–center retrospective cohort study
by: Jie Gao, et al.
Published: (2025-07-01) -
Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients
by: Laura E. Martínez-Gómez, et al.
Published: (2025-08-01)